The Issue: Lack of Funding for Cancer Research
Cancer is the leading cause of death in Canada, killing one in four Canadians, including more than 78,000 in 2015 alone. Research taking part across the country aims to improve the prognosis. Today, about 63% of cancer patients survive the disease; several forms of cancer have greatly increased survival rates, including 90% for breast cancer and 95% for prostate cancer.
However, hundreds of applications for research grants are submitted every year by scientists seeking to make life-saving breakthroughs. The Cancer Research Society and other not-for-profit organizations are in constant need of funding to support scientifically sound research projects. A lack of funding inhibits opportunities for treatments and cures.
The Campaign: Funding Scientific Cancer Research
All donations to this Grassroots campaign will be used by the Cancer Research Society to fund research that could discover effective cancer treatments and increase survival rates. For every $5, $10, $20, $50, or $100 raised, the Cancer Research Society will be able to provide grants to cancer researchers looking for ways to treat and cure the disease. The organization receives hundreds of funding applications every year from scientists across the country, and it seeks to provide grants to as many research projects as possible.
Cancer Research Society
Anyone could discover the cure for cancer. No one knows who it will be, when or where it will happen. That's why the Cancer Research Society has been providing grants for scientists investigating causes, diagnoses, and treatments since 1945, becoming the first Canadian organization to do so as its sole mission. The society supports research on all types of cancer, distributing funds to projects based on scientific merit so that deserving researchers in all sorts of fields have a chance to uncover new ways to prevent, detect, and treat this family of diseases. Thanks to donors and partners, projects funded by the Cancer Research Society have resulted in a number of breakthroughs—particularly for breast cancer and leukemia—and played a pioneering role in the field of environmental cancer.